A Long-Term Study of Photodynamic Therapy with Verteporfin for Choroidal Neovascularization at the Edge of Chorioretinal Atrophy in Pathologic Myopia

Publisher： Karger

E-ISSN： 1423-0267|225|3|161-168

ISSN： 0030-3755

Source： Ophthalmologica, Vol.225, Iss.3, 2011-01, pp. : 161-168

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Photodynamic Therapy Using Verteporfin for Choroidal Neovascularization Associated with Angioid Streaks – Long-Term Effects

By  

Ophthalmic Research, Vol. 38, Iss. 4, 2006-08 ,pp. : 209-217

Karger

Access to resources Recommend Favorite

Photodynamic Therapy for Choroidal Neovascularization

By  

Ophthalmologica, Vol. 215, Iss. 2, 2001-12 ,pp. : 27-36

Karger

Access to resources Recommend Favorite

Optical Coherence Tomography Following Photodynamic Therapy With Verteporfin for Subfoveal Predominantly Classic Choroidal Neovascularization

By  

Annals of Ophthalmology, Vol. 38, Iss. 2, 2006-06 ,pp. : 121-126

Humana Press, Inc

Access to resources Recommend Favorite

Efficacy of verteporfin photodynamic therapy on laser-induced choroidal neovascularization and the ancillary effect on diabetic microvasculopathy

By Taban Mehryar   Thomas Edgar L.   Boyer David S.   Novack Roger L.   Chu Thomas G.   Gallemore Ron P.  

Current Eye Research, Vol. 28, Iss. 4, 2004-04 ,pp. : 291-295

Informa Healthcare

Access to resources Recommend Favorite

Anti-VEGF Therapy in Myopic Choroidal Neovascularization: Long-Term Results

By  

Ophthalmologica, Vol. 232, Iss. 1, 2014-05 ,pp. : 57-63

Karger

Access to resources Recommend Favorite